WORCESTER, Mass. and TORONTO, July 5, 2011 /PRNewswire/ -- Generex Biotechnology Corporation (OTCBB: GNBT) (www.generex.com) today announced that it has engaged Congressman Curt Weldon to assist in supporting the strategic development plan unveiled by the Company at a press conference in New York City on March 30, 2011.
Congressman Weldon will source, evaluate, and introduce Generex to business and funding avenues, including licensing and research grant opportunities, in China, Taiwan, the United States Armed Services, and the global healthcare sector. Congressman Weldon will also provide advice and assistance to the Company in its relationships with governments and governmental agencies.
Congressman Weldon served in the US Congress for 20 years (1987-2007) and retired as Vice Chair of the Military Oversight Committee (HASC) as well as Vice Chair of the Homeland Security Committee. During his tenure, Weldon also served as a senior Member of the Science Committee and Chair of the Defense Research Committee where he provided oversight for all funding for the National Institutes of Health (NIH), the National Science Foundation (NSF) as well as all Military Medical Research Funding. Weldon also founded and Chaired the 4 State SMART Research Initiative. Weldon founded and Co-Chaired the Congressional Diabetes Caucus. He has keynoted multiple national Diabetes Group Conferences, won several National Diabetes Awards and is married to Mary Weldon, RN and a Certified Diabetes Educator.
During his 20 year tenure in Congress, Weldon founded and Co-Chaired bi-lateral Parliamentary Relationships with 12 countries and led bipartisan Congressional Delegation trips to over 100 nations worldwide. Weldon maintains high-level personal international business and government relationships and sits on the Boards of two in
|SOURCE Generex Biotechnology Corporation|
Copyright©2010 PR Newswire.
All rights reserved